Edwards Lifesciences to Present at the Goldman Sachs and William Blair
IRVINE, CA -- (Marketwired) -- 06/04/13 -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, is scheduled to present at two
upcoming conferences on Tuesday, June 11, 2013. Thomas M. Abate,
Edwards' corporate vice president and chief financial officer, is
scheduled to speak to attendees of the Goldman Sachs 34th Annual
Global Healthcare Conference at the Terranea Resort in Rancho Palos
Verdes, California at 8:00 a.m. PDT. That same day, Donald E. Bobo,
Edwards' corporate vice president, heart valve therapy, is scheduled
to speak at the William Blair 33rd Annual Growth Stock Conference at
the Four Seasons Hotel in Chicago, Illinois at 2:50 p.m. CDT.
Live webcasts of both presentations will be available to all
interested parties on the Edwards Lifesciences investor relations
website at http://ir.edwards.com. Following each presentation, an
archived version of the webcast will be available on the Edwards
investor relations website in the News and Events section and via the
Edwards Lifesciences Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart
valves and hemodynamic monitoring. Driven by a passion to help
patients, the company partners with clinicians to develop innovative
technologies in the areas of structural heart disease and critical
care monitoring that enable them to save and enhance lives.
Additional company information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.
David K. Erickson
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614
Press spacebar to pause and continue. Press esc to stop.